Acumen Pharmaceuticals, Inc.
ABOS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001576885
No open-market purchases or sales by Acumen Pharmaceuticals, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $127.8M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Acumen Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 81 | 71 | −10 |
| Shares | 40.3M | 37.6M | −2.66M (−6.6%) |
| Value | $44.8M | $43.6M | −$1.20M (−2.7%) |
New holders (17)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 250,848 | $291.0K | 0.01% |
| Marshall Wace, LLP | 137,943 | $160.0K | 0.00% |
| Jain Global LLC | 39,990 | $46.4K | 0.00% |
| Gsa Capital Partners LLP | 32,103 | $37.0K | 0.00% |
| HRT Financial LP | 31,427 | $36.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 21,340 | $24.8K | 0.00% |
| Catalyst Funds Management Pty Ltd | 19,700 | $22.9K | 0.01% |
| Schonfeld Strategic Advisors LLC | 15,929 | $18.5K | 0.00% |
| Savant Capital, LLC | 11,045 | $12.8K | 0.00% |
| DRW Securities, LLC | 11,018 | $12.8K | 0.00% |
| Ethic Inc. | 11,377 | $12.7K | 0.00% |
| Nisa Investment Advisors, LLC | 1,229 | $1.43K | 0.00% |
| Skopos Labs, Inc. | 619 | $719 | 0.00% |
| Raymond James Financial Inc | 495 | $574 | 0.00% |
| NBT Bank N A | 200 | $232 | 0.00% |
| Farther Finance Advisors, LLC | 200 | $232 | 0.00% |
| Clearstead Advisors, LLC | 63 | $74 | 0.00% |
Sold out (27)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.